Summary
2007, Vol. 37, No. 6, Pages 618-634

Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H2-blockers on human and rat organic cation transporter-mediated transport: Insight into the development of drug candidates

K.-I. Umehara, T. Iwatsubo, K. Noguchi and H. Kamimura
Drug Metabolism Research Laboratories, Drug Discovery Research, Astellas Pharma Inc., Tokyo, Japan

Drug Metabolism Research Laboratories, Drug Discovery Research, Astellas Pharma Inc., 1-8, Azusawa 1-chome, Itabashi-ku, Tokyo, 174-8511, Japan, +81-3-5916-2161, +81-3-3960-2161



In this study, the comparison of the transport of substrates (1-methyl-4-phenylpydinium (MPP) and tetraethyl ammonium (TEA)) and the inhibition potency of the inhibitors (biguanides and H2-blockers) for human and rat organic cation transporters (hOCTs and rOcts), and the inhibition type of inhibitors for these transporters were investigated using HEK293 cells that stably express hOCT/rOct. The concentration-dependent uptake of [3H]-MPP and [14C]-TEA by hOCT1-3/rOct1-3 had Km values similar to those in the literature. It was also deduced that MPP and TEA are competitive inhibitors for hOCT1-2/rOct1-2. The Ki values for phenformin inhibition of [3H]-MPP and [14C]-TEA uptake by hOCT1-3/rOct1-3 were lower than that for metformin. The [3H]-MPP uptake by hOCT1/rOct1 and hOCT3/rOct3 was inhibited by famotidine and ranitidine whereas that by hOCT2/rOct2 was not. The inhibitory potency of cimetidine for hOCT1-2 was very weak. In most cases, the differences in the Vmax/Km values of substrates and the Ki values of inhibitors between hOCT and rOct were minor. The acquisition of information on OCT/Oct mediated-transport and/or inhibition such as that presented in this report is very useful for further understanding of certain aspects of uptake, distribution, and excretion for drug candidates.

Full Text | PDF (150 KB) | PDF Plus (219 KB)

Forward Links to Citing Articles

Jürgen Kindla, Martin F Fromm, Jörg König. (2009) In vitro evidence for the role of OATP and OCT uptake transporters in drug–drug interactions. Expert Opinion on Drug Metabolism & Toxicology 5:5, 489-500
Online publication date: 1-May-2009.
Summary | Full Text | PDF (455 KB) | PDF Plus (456 KB) 
K.-I. Umehara, K. Seya, T. Iwatsubo, K. Noguchi, T. Usui, H. Kamimura. (2008) Tissue distribution of YM758, a novel If channel inhibitor, in pregnant and lactating rats. Xenobiotica 38:10, 1274-1288
Online publication date: 1-Oct-2008.
Summary | Full Text | PDF (898 KB) | PDF Plus (968 KB) 
K.-I. Umehara, T. Iwatsubo, K. Noguchi, T. Usui, H. Kamimura. (2008) Effect of cationic drugs on the transporting activity of human and rat OCT/Oct 1–3 in vitro and implications for drug–drug interactions. Xenobiotica 38:9, 1203-1218
Online publication date: 1-Sep-2008.
Summary | Full Text | PDF (147 KB) | PDF Plus (224 KB) 
K.-I. Umehara, T. Iwatsubo, K. Noguchi, H. Kamimura. (2007) Functional involvement of organic cation transporter1 (OCT1/Oct1) in the hepatic uptake of organic cations in humans and rats. Xenobiotica 37:8, 818-831
Online publication date: 1-Aug-2007.
Summary | Full Text | PDF (125 KB) | PDF Plus (179 KB) 

 

Prev. Article | Next Article
View/Print PDF (150 KB)
View PDF Plus (219 KB)
Add to favourite
Email to a friend
TOC Alert | Citation Alert What is RSS?

 
 
Quick Search
for 
Authors:
K.-I. Umehara
T. Iwatsubo
K. Noguchi
H. Kamimura
Keywords:
hOCT/rOct
uptake of cationic compounds
transporter uptake
transporter inhibition
organic cation transporters